By Jennifer Bright and Michael Thompson
It has been standard practice for employers to rely on their plans, PBMs, and consultants to make recommendations about coverage and formularies, and define the metrics that determine value. However, there is a growing gap between the management of those functions and how value is assessed by employers, other purchasers, and patients. Here we use one example — management of depression — as a case study in how purchasers and patients could better assess value. This is particularly timely with the COVID-19 pandemic which will likely lead to more mental health issues.
